20-34303394-G-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001161766.2(AHCY):c.-56-7809C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.85 in 1,379,294 control chromosomes in the GnomAD database, including 510,108 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 44081 hom., cov: 36)
Exomes 𝑓: 0.87 ( 466027 hom. )
Consequence
AHCY
NM_001161766.2 intron
NM_001161766.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.430
Genes affected
AHCY (HGNC:343): (adenosylhomocysteinase) S-adenosylhomocysteine hydrolase belongs to the adenosylhomocysteinase family. It catalyzes the reversible hydrolysis of S-adenosylhomocysteine (AdoHcy) to adenosine (Ado) and L-homocysteine (Hcy). Thus, it regulates the intracellular S-adenosylhomocysteine (SAH) concentration thought to be important for transmethylation reactions. Deficiency in this protein is one of the different causes of hypermethioninemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 20-34303394-G-T is Benign according to our data. Variant chr20-34303394-G-T is described in ClinVar as [Benign]. Clinvar id is 338286.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.88 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AHCY | NM_000687.4 | c.-124C>A | upstream_gene_variant | ENST00000217426.7 | NP_000678.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AHCY | ENST00000538132.1 | c.-56-7809C>A | intron_variant | Intron 1 of 9 | 2 | ENSP00000442820.1 | ||||
AHCY | ENST00000217426.7 | c.-124C>A | upstream_gene_variant | 1 | NM_000687.4 | ENSP00000217426.2 | ||||
AHCY | ENST00000480653.5 | n.-77C>A | upstream_gene_variant | 2 | ||||||
AHCY | ENST00000606061.1 | n.-37C>A | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.721 AC: 109714AN: 152172Hom.: 44053 Cov.: 36
GnomAD3 genomes
AF:
AC:
109714
AN:
152172
Hom.:
Cov.:
36
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.866 AC: 1063019AN: 1227004Hom.: 466027 Cov.: 18 AF XY: 0.865 AC XY: 529727AN XY: 612600
GnomAD4 exome
AF:
AC:
1063019
AN:
1227004
Hom.:
Cov.:
18
AF XY:
AC XY:
529727
AN XY:
612600
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.721 AC: 109780AN: 152290Hom.: 44081 Cov.: 36 AF XY: 0.724 AC XY: 53899AN XY: 74466
GnomAD4 genome
AF:
AC:
109780
AN:
152290
Hom.:
Cov.:
36
AF XY:
AC XY:
53899
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2699
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 08, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Hypermethioninemia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at